Mechanisms and regulation of neurotrophin synthesis and secretion

References

1. ↵
   1. Skaper SD

   (2012) The neurotrophin family of neurotrophic factors: an overview. Methods Mol Biol 846, 1–12.
2. 1. Loughlin SE,
   2. Fallon JH

   , eds (2012) Neurotrophic factors (Elsevier, San Diego (CA)).
3. ↵
   1. Lewin GR,
   2. Carter BD

   1. Bothwell M

   (2014) NGF, BDNF, NT3, and NT4. in Neurotrophic Factors, eds Lewin GR, Carter BD (Springer, New York (NY)), 3–15.
4. ↵
   1. Caporali A,
   2. Emanueli C

   (2009) Cardiovascular actions of neurotrophins. Physiol Rev 89, 279–308.
5. ↵
   1. Deinhardt K,
   2. Chao MV

   (2014) Trk receptors. Handb Exp Pharmacol 220, 103–119.
6. ↵
   1. Lemmon MA,
   2. Schlessinger J

   (2010) Cell signaling by receptor tyrosine kinases. Cell 141, 1117–1134.
7. ↵
   1. Rafieva LM,
   2. Gasanov EV

   (2016) Neurotrophin Propeptides: Biological Functions and Molecular Mechanisms. Curr Protein Pept Sci 17, 298–305.
8. 1. Numakawa T,
   2. Suzuki S,
   3. Kumamaru E,
   4. Adachi N,
   5. Richards M,
   6. Kunugi H

   (2010) BDNF function and intracellular signaling in neurons. Histol Histopathol 25, 237–258.
9. ↵
   1. Lessmann V,
   2. Brigadski T

   (2009) Mechanisms, locations, and kinetics of synaptic BDNF secretion: an update. Neurosci Res 65, 11–22.
10. ↵
    1. Paoletti F,
    2. Covaceuszach S,
    3. Konarev PV,
    4. Gonfloni S,
    5. Malerba F,
    6. Schwarz E,
    7. et al.

    (2009) Intrinsic structural disorder of mouse proNGF. Proteins 75, 990–1009.
11. ↵
    1. Urban D,
    2. Lorenz J,
    3. Meyborg H,
    4. Ghosh S,
    5. Kintscher U,
    6. Kaufmann J,
    7. et al.

    (2013) Proprotein convertase furin enhances survival and migration of vascular smooth muscle cells via processing of pro-nerve growth factor. J Biochem 153, 197–207.
12. ↵
    1. Bradshaw RA,
    2. Pundavela J,
    3. Biarc J,
    4. Chalkley RJ,
    5. Burlingame AL,
    6. Hondermarck H

    (2015) NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling. Adv Biol Regul 58, 16–27.
13. ↵
    1. Lessmann V,
    2. Brigadski T

    (2009) Mechanisms, locations, and kinetics of synaptic BDNF secretion: an update. Neurosci Res 65, 11–22.
14. ↵
    1. Capsoni S,
    2. Amato G,
    3. Vignone D,
    4. Criscuolo C,
    5. Nykjaer A,
    6. Cattaneo A

    (2013) Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation. Biochemical and biophysical research communications 431, 579–585.
15. ↵
    1. Evans SF,
    2. Irmady K,
    3. Ostrow K,
    4. Kim T,
    5. Nykjaer A,
    6. Saftig P,
    7. et al.

    (2011) Neuronal brain-derived neurotrophic factor is synthesized in excess, with levels regulated by sortilin-mediated trafficking and lysosomal degradation. J Biol Chem 286, 29556–29567.
16. ↵
    1. Dincheva I,
    2. Glatt CE,
    3. Lee FS

    (2012) Impact of the BDNF Val66Met polymorphism on cognition: implications for behavioral genetics. Neuroscientist 18, 439–451.
17. ↵
    1. Hempstead BL

    (2015) Brain-Derived Neurotrophic Factor: Three Ligands, Many Actions. Trans Am Clin Climatol Assoc 126, 9–19.
18. ↵
    1. Cheng Y,
    2. Cawley NX,
    3. Loh YP

    (2014) Carboxypeptidase E (NF-alpha1): a new trophic factor in neuroprotection. Neurosci Bull 30, 692–696.
19. ↵
    1. Adachi N,
    2. Numakawa T,
    3. Richards M,
    4. Nakajima S,
    5. Kunugi H

    (2014) New insight in expression, transport, and secretion of brain-derived neurotrophic factor: Implications in brain-related diseases. World J Biol Chem 5, 409–428.
20. ↵
    1. Lin WJ,
    2. Salton SR

    (2013) The regulated secretory pathway and human disease: insights from gene variants and single nucleotide polymorphisms. Front Endocrinol (Lausanne) 4, 96.
21. ↵
    1. Notaras M,
    2. Hill R,
    3. van den Buuse M

    (2015) A role for the BDNF gene Val66Met polymorphism in schizophrenia? A comprehensive review. Neurosci Biobehav Rev 51, 15–30.
22. ↵
    1. Eisenberg DP,
    2. Ianni AM,
    3. Wei SM,
    4. Kohn PD,
    5. Kolachana B,
    6. Apud J,
    7. et al.

    (2013) Brain-derived neurotrophic factor (BDNF) Val(66)Met polymorphism differentially predicts hippocampal function in medication-free patients with schizophrenia. Mol Psychiatry 18, 713–720.
23. ↵
    1. Anastasia A,
    2. Deinhardt K,
    3. Chao MV,
    4. Will NE,
    5. Irmady K,
    6. Lee FS,
    7. et al.

    (2013) Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction. Nat Commun 4, 2490.
24. ↵
    1. Kienzle C,
    2. von Blume J

    (2014) Secretory cargo sorting at the trans-Golgi network. Trends Cell Biol 24, 584–593.
25. ↵
    1. Al-Qudah M,
    2. Anderson CD,
    3. Mahavadi S,
    4. Bradley ZL,
    5. Akbarali HI,
    6. Murthy KS,
    7. et al.

    (2014) Brain-derived neurotrophic factor enhances cholinergic contraction of longitudinal muscle of rabbit intestine via activation of phospholipase C. Am J Physiol Gastrointest Liver Physiol 306, G328–G337.
26. ↵
    1. Nagappan G,
    2. Zaitsev E,
    3. Senatorov VV Jr.,
    4. Yang J,
    5. Hempstead BL,
    6. Lu B

    (2009) Control of extracellular cleavage of ProBDNF by high frequency neuronal activity. Proc Natl Acad Sci U S A 106, 1267–1272.
27. ↵
    1. Beggs S,
    2. Alvares D,
    3. Moss A,
    4. Currie G,
    5. Middleton J,
    6. Salter MW,
    7. et al.

    (2012) A role for NT-3 in the hyperinnervation of neonatally wounded skin. Pain 153, 2133–2139.
28. ↵
    1. von Bartheld CS

    1. Trafficking of Neurotrophins and Their Receptors and Pathological Significance

    (2014) Handbook of Neurotoxicity, ed von Bartheld CS (Springer, New York (NY)), 1973–2000.
29. ↵
    1. Guo L,
    2. Yeh ML,
    3. Cuzon Carlson VC,
    4. Johnson-Venkatesh EM,
    5. Yeh HH

    (2012) Nerve growth factor in the hippocamposeptal system: evidence for activity-dependent anterograde delivery and modulation of synaptic activity. J Neurosci 32, 7701–7710.
30. ↵
    1. Gottmann K,
    2. Mittmann T,
    3. Lessmann V

    (2009) BDNF signaling in the formation, maturation and plasticity of glutamatergic and GABAergic synapses. Exp Brain Res 199, 203–334.
31. ↵
    1. Greenberg ME,
    2. Xu B,
    3. Lu B,
    4. Hempstead BL

    (2009) New insights in the biology of BDNF synthesis and release: implications in CNS function. J Neurosci 29, 12764–12767.
32. ↵
    1. Teng KK,
    2. Felice S,
    3. Kim T,
    4. Hempstead BL

    (2010) Understanding proneurotrophin actions: recent advances and challenges. Dev Neurobiol 70, 350–359.
33. ↵
    1. Nomoto H,
    2. Takaiwa M,
    3. Mouri A,
    4. Furukawa S

    (2007) Pro-region of neurotrophins determines the processing efficiency. Biochem Biophys Res Commun 356, 919–924.
34. ↵
    1. Kuczewski N,
    2. Porcher C,
    3. Lessmann V,
    4. Medina I,
    5. Gaiarsa JL

    (2009) Activity-dependent dendritic release of BDNF and biological consequences. Mol Neurobiol 39, 37–49.
35. ↵
    1. Kolarow R,
    2. Brigadski T,
    3. Lessmann V

    (2007) Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening. J Neurosci 27, 10350–10364.
36. ↵
    1. Jang HJ,
    2. Yang YR,
    3. Kim JK,
    4. Choi JH,
    5. Seo YK,
    6. Lee YH,
    7. et al.

    (2013) Phospholipase C-gamma1 involved in brain disorders. Adv Biol Regul 53, 51–62.
37. ↵
    1. Bagayogo IP,
    2. Dreyfus CF

    (2009) Regulated release of BDNF by cortical oligodendrocytes is mediated through metabotropic glutamate receptors and the PLC pathway. ASN Neuro, 1.
38. ↵
    1. Eckenstaler R,
    2. Lessmann V,
    3. Brigadski T

    (2016) CAPS1 effects on intragranular pH and regulation of BDNF release from secretory granules in hippocampal neurons. J Cell Sci 129, 1378–1390.
39. ↵
    1. Zheng H,
    2. Fan J,
    3. Xiong W,
    4. Zhang C,
    5. Wang XB,
    6. Liu T,
    7. et al.

    (2009) Action potential modulates Ca2+-dependent and Ca2+-independent secretion in a sensory neuron. Biophys J 96, 2449–2456.
40. ↵
    1. Vermehren-Schmaedick A,
    2. Khanjian RA,
    3. Balkowiec A

    (2015) Cellular mechanisms of activity-dependent BDNF expression in primary sensory neurons. Neuroscience 310, 665–673.
41. ↵
    1. Kolarow R,
    2. Brigadski T,
    3. Lessmann V

    (2007) Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening. J Neurosci 27, 10350–10364.
42. ↵
    1. Cheng PL,
    2. Song AH,
    3. Wong YH,
    4. Wang S,
    5. Zhang X,
    6. Poo MM

    (2011) Self-amplifying autocrine actions of BDNF in axon development. Proc Natl Acad Sci U S A 108, 18430–18435.
43. ↵
    1. Wong YH,
    2. Lee CM,
    3. Xie W,
    4. Cui B,
    5. Poo MM

    (2015) Activity-dependent BDNF release via endocytic pathways is regulated by synaptotagmin-6 and complexin. Proc Natl Acad Sci U S A 112, E4475–E4484.
44. ↵
    1. Luo B,
    2. Huang J,
    3. Lu L,
    4. Hu X,
    5. Luo Z,
    6. Li M

    (2014) Electrically induced brain-derived neurotrophic factor release from Schwann cells. J Neurosci Res 92, 893–903.
45. ↵
    1. Streit WJ,
    2. Xue QS

    (2012) Alzheimer’s disease, neuroprotection, and CNS immunosenescence. Front Pharmacol 3, 138.
46. ↵
    1. Ortega JA,
    2. Alcántara S

    (2010) BDNF/MAPK/ERK-induced BMP7 expression in the developing cerebral cortex induces premature radial glia differentiation and impairs neuronal migration. Cereb Cortex 20, 2132–2144.
47. ↵
    1. Kolarow R,
    2. Kuhlmann CR,
    3. Munsch T,
    4. Zehendner C,
    5. Brigadski T,
    6. Luhmann HJ,
    7. et al.

    (2014) BDNF-induced nitric oxide signals in cultured rat hippocampal neurons: time course, mechanism of generation, and effect on neurotrophin secretion. Front Cell Neurosci 8, 323.
48. ↵
    1. Lim KC,
    2. Tyler CM,
    3. Lim ST,
    4. Giuliano R,
    5. Federoff HJ

    (2007) Proteolytic processing of proNGF is necessary for mature NGF regulated secretion from neurons. Biochem Biophys Res Commun 361, 599–604.
49. ↵
    1. Krüttgen A,
    2. Möller JC,
    3. Heymach JV,
    4. Shooter EM

    (1998) Neurotrophins induce release of neurotrophins by the regulated secretory pathway. Proc Natl Acad Sci U S A 95, 9614–9619.
50. ↵
    1. Raap U,
    2. Braunstahl GJ

    (2010) The role of neurotrophins in the pathophysiology of allergic rhinitis. Curr Opin Allergy Clin Immunol 10, 8–13.
51. ↵
    1. Iwamoto T,
    2. Yamada A,
    3. Arakaki M,
    4. Sugawara Y,
    5. Ono M,
    6. Futaki M,
    7. et al.

    (2011) Expressions and Functions of Neurotrophic Factors in Tooth Development. Journal of Oral Biosciences 53, 13–21.
52. ↵
    1. Al-Qudah M,
    2. Alkahtani R,
    3. Akbarali HI,
    4. Murthy KS,
    5. Grider JR

    (2015) Stimulation of synthesis and release of brain-derived neurotropic factor from intestinal smooth muscle cells by substance P and pituitary adenylate cyclase-activating peptide. Neurogastroenterol Motil 27, 1162–1174.
53. ↵
    1. Prakash YS,
    2. Martin RJ

    (2014) Brain-derived neurotrophic factor in the airways. Pharmacol Ther 143, 74–86.
54. 1. Wang S,
    2. Freeman MR,
    3. Sathish V,
    4. Thompson MA,
    5. Pabelick CM,
    6. Prakash YS

    (2016) Sex Steroids Influence Brain-Derived Neurotropic Factor Secretion From Human Airway Smooth Muscle Cells. J Cell Physiol 231, 1586–1592.
55. ↵
    1. Prakash YS,
    2. Thompson MA,
    3. Pabelick CM

    (2009) Brain-derived neurotrophic factor in TNF-alpha modulation of Ca2+in human airway smooth muscle. Am J Respir Cell Mol Biol 41, 603–611.
56. ↵
    1. Thompson MA,
    2. Britt RD Jr.,
    3. Kuipers I,
    4. Stewart A,
    5. Thu J,
    6. Pandya HC,
    7. et al.

    (2015) cAMP-mediated secretion of brain-derived neurotrophic factor in developing airway smooth muscle. Biochim Biophys Acta 1853, 2506–2014.
57. ↵
    1. Jesenak M,
    2. Babusikova E,
    3. Evinova A,
    4. Banovcin P,
    5. Dobrota D

    (2015) Val66Met polymorphism in the BDNF gene in children with bronchial asthma. Pediatr Pulmonol 50, 631–637.
58. ↵
    1. Szczepankiewicz A,
    2. Breborowicz A,
    3. Sobkowiak P,
    4. Popiel A

    (2010) Association of BDNF gene polymorphism with asthma in polish children. World Allergy Organ J 3, 235–238.
59. ↵
    1. Rachaneni S,
    2. Arya P,
    3. Latthe P

    (2013) Urinary nerve growth factor: a biomarker of detrusor overactivity? A systematic review. Int Urogynecol J 24, 1603–1609.
60. 1. Wang JH,
    2. Chen BG,
    3. Yin J,
    4. Wang G,
    5. Zou WG,
    6. Luo XJ

    (2009) [Effect of electroacupuncture of different acupoints on the excitability of detrusor muscle and the expression of BDNF and TrkB in the spinal cord of rats with urinary retention due to spinal cord injury]. Zhen Ci Yan Jiu 34, 387–392, Chinese.
61. ↵
    1. Girard BM,
    2. Malley SE,
    3. Braas KM,
    4. May V,
    5. Vizzard MA

    (2010) PACAP/VIP and receptor characterization in micturition pathways in mice with overexpression of NGF in urothelium. J Mol Neurosci 42, 378–389.
62. ↵
    1. Cho YS,
    2. Ko IG,
    3. Kim SE,
    4. Hwan L,
    5. Shin MS,
    6. Kim CJ,
    7. et al.

    (2014) Caffeine enhances micturition through neuronal activation in micturition centers. Mol Med Rep 10, 2931–2936.
63. ↵
    1. Grider JR,
    2. Piland BE,
    3. Gulick MA,
    4. Qiao LY

    (2006) Brain-derived neurotrophic factor augments peristalsis by augmenting 5-HT and calcitonin gene-related peptide release. Gastroenterology 130, 771–780.
64. ↵
    1. Emanueli C,
    2. Meloni M,
    3. Hasan W,
    4. Habecker BA

    (2014) The biology of neurotrophins: cardiovascular function. Handb Exp Pharmacol 220, 309–328.
65. ↵
    1. Campagnolo L,
    2. Costanza G,
    3. Francesconi A,
    4. Arcuri G,
    5. Moscatelli I,
    6. Orlandi A

    (2014) Sortilin expression is essential for pro-nerve growth factor-induced apoptosis of rat vascular smooth muscle cells. PLoS One 9, e84969.